Evaluating Treatment Patterns, Relapses, Healthcare Resource Utilization, and Costs Associated with Disease-Modifying Treatments for Multiple Sclerosis in DMT-Naïve Patients

por Freeman, Leorah, Kee, Arianna, Tian, Marc, Mehta, Rina
Publicado 2021

Retrospective Claims Analysis of Treatment Patterns, Relapse, Utilization, and Cost Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy

por Freeman, Leorah, Kee, Arianna, Tian, Marc, Mehta, Rina
Publicado 2021

Switch Rates and Total Cost of Care Associated with Apremilast and Biologic Therapies in Biologic-Naive Patients with Plaque Psoriasis

por Kaplan, David L, Ung, Brian L, Pelletier, Corey, Udeze, Chuka, Khilfeh, Ibrahim, Tian, Marc
Publicado 2020

Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis

por Wu, Jashin J., Pelletier, Corey, Ung, Brian, Tian, Marc, Khilfeh, Ibrahim, Curtis, Jeffrey R.
Publicado 2020

Productivity Loss and Associated Costs Among Employed Patients Receiving Disease-Modifying Treatment for Multiple Sclerosis

por Bonafede, Machaon, Mehta, Rina, Kim, Gilwan, Sruti, Ila, Tian, Marc, Pelletier, Corey, Goldfarb, Neil
Publicado 2020

Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy

por Bowen, James, Mehta, Rina, Pelletier, Corey, Tian, Marc, Noxon, Virginia, Johnson, Barbara H., Bonafede, Machaon
Publicado 2020

Early versus late administration of long-acting injectable antipsychotic agents among patients with newly diagnosed schizophrenia: an analysis of a commercial claims database

por Kane, John M., Chen, Anna, Lim, Sangtaeck, Mychaskiw, Marko A., Tian, Marc, Wang, Yitong, Suett, Mark, Rubio, Jose M.
Publicado 2023